Discontinued — last reported Q1 '19
An increase suggests higher transaction volumes or improved pricing power within the sequencing segment, whereas a decrease could reflect lower contract activity or changes in tax-inclusive pricing strategies.
This metric captures the total transaction price allocated to performance obligations within the sequencing segment, inc...
Comparable to 'Gross Revenue' or 'Total Contract Revenue' reported by other diagnostic and life science instrumentation companies under IFRS or GAAP revenue recognition standards.
ilmn_segment_sequencing_revenue_from_contract_with_customer_including_assessed_tax